Exelixis
EXEL
#1568
Rank
A$19.66 B
Marketcap
A$79.35
Share price
-0.68%
Change (1 day)
36.07%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company